UCD0168 is a serotonin releasing agent (SRA) of the tropane family related to the tryptamines. It is potent, selective, and shows full efficacy as an SRA in serotonin transporter (SERT)-transfected HEK293T cells. This includes selectivity for the SERT over the dopamine transporter (DAT) and norepinephrine transporter (NET). However, the drug also shows substantial interaction with the serotonin 5-HT3 receptor and the sigma σ1 and σ2 receptor (92.5–95.1% binding inhibition, relative to 94.9% at the SERT). The chemical synthesis of UCD0168 has been described. Analogues of UCD0168 have been described, for instance UCD0820, which is a poorly selective SRA with partial releasing efficacy. UCD0168 was first described in the scientific literature by David E. Olson and colleagues at the University of California, Davis (UCD) in 2025.
References


